Latest filing published 12 May 2026 for AbbVie Inc.. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Jennifer L. Davis across 2 companies, led by PROCTER & GAMBLE Co and AbbVie Inc. Over a trading history stretching from 16 August 2022 to 8 May 2026, the count stands at 20 filings.
The open-market record consists of 6 sales worth €4.2M, with no purchase. The rest of the record consists of 8 share grants and 6 option exercises.
The latest filing, published on 12 May 2026, reports a share grant in AbbVie Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations